We Think You Should Be Aware Of Some Concerning Factors In Vittia Fertilizantes e Biológicos' (BVMF:VITT3) Earnings

By
Simply Wall St
Published
March 23, 2022
BOVESPA:VITT3
Source: Shutterstock

The market for Vittia Fertilizantes e Biológicos S.A.'s (BVMF:VITT3) stock was strong after it released a healthy earnings report last week. Despite this, our analysis suggests that there are some factors weakening the foundations of those good profit numbers.

View our latest analysis for Vittia Fertilizantes e Biológicos

earnings-and-revenue-history
BOVESPA:VITT3 Earnings and Revenue History March 23rd 2022

A Closer Look At Vittia Fertilizantes e Biológicos' Earnings

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

Vittia Fertilizantes e Biológicos has an accrual ratio of 0.23 for the year to December 2021. Therefore, we know that it's free cashflow was significantly lower than its statutory profit, which is hardly a good thing. In the last twelve months it actually had negative free cash flow, with an outflow of R$25m despite its profit of R$107.1m, mentioned above. We also note that Vittia Fertilizantes e Biológicos' free cash flow was actually negative last year as well, so we could understand if shareholders were bothered by its outflow of R$25m.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Vittia Fertilizantes e Biológicos' Profit Performance

Vittia Fertilizantes e Biológicos' accrual ratio for the last twelve months signifies cash conversion is less than ideal, which is a negative when it comes to our view of its earnings. Therefore, it seems possible to us that Vittia Fertilizantes e Biológicos' true underlying earnings power is actually less than its statutory profit. But on the bright side, its earnings per share have grown at an extremely impressive rate over the last three years. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you want to do dive deeper into Vittia Fertilizantes e Biológicos, you'd also look into what risks it is currently facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Vittia Fertilizantes e Biológicos.

Today we've zoomed in on a single data point to better understand the nature of Vittia Fertilizantes e Biológicos' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.